摘要
Several case reports deal with the relationship between hepatitis C virus (HCV) infection and pulmonary or he- patic sarcoidosis. Most publications describe interferon m-induced sarcoidosis. However, HCV infection per se is also suggested to cause sarcoqdosis. The present case report describes a case of biopsy-verified lung and liver sarcoidosis and HCV infection, and the out- come of antiviral therapy. In March 2009, a 25-year-old man presented with moderately elevated liver enzymes without any clinical symptoms. The patient was posi- tive for HCV antibodies and HCV RNA of genotype lb. Four months later the patient became dyspnoic and pulmonary sarcoidosis was diagnosed by lung biopsy and radiography. A short course of corticosteroid treat- ment relieved symptoms. Three months later, liver biopsy showed noncaseating granulomas consisting of epithelioid histiocytes and giant cells with a small amount of peripheral lymphocyte infiltration, without any signs of fibrosis. Chronic HCV infection with co- existence of pulmonary and hepatic sarcoidosis was diagnosed. Antiviral therapy with peginterferon ~ and ribavirin at standard doses was started, which lasted 48 wk, and sustained viral response was achieved. A second liver biopsy showed disappearance of granulo- mas and chest radiography revealed normalization of mediastinal and perihilar glands. The hypothesis that HCV infection perse may have triggered systemic sar- coidosis was proposed. Successful treatment of HCV infection led to continuous remission of pulmonary and hepatic sarcoidosis. Further studies are required to un- derstand the relationship between systemic sarcoidosis and HCV infection.
Several case reports deal with the relationship between hepatitis C virus(HCV) infection and pulmonary or hepatic sarcoidosis.Most publications describe interferon-induced sarcoidosis.However,HCV infection per se is also suggested to cause sarcoidosis.The present case report describes a case of biopsy-verified lung and liver sarcoidosis and HCV infection,and the outcome of antiviral therapy.In March 2009,a 25-year-old man presented with moderately elevated liver enzymes without any clinical symptoms.The patient was positive for HCV antibodies and HCV RNA of genotype 1b.Four months later the patient became dyspnoic and pulmonary sarcoidosis was diagnosed by lung biopsy and radiography.A short course of corticosteroid treatment relieved symptoms.Three months later,liver biopsy showed noncaseating granulomas consisting of epithelioid histiocytes and giant cells with a small amount of peripheral lymphocyte infiltration,without any signs of fibrosis.Chronic HCV infection with coexistence of pulmonary and hepatic sarcoidosis was diagnosed.Antiviral therapy with peginterferon and ribavirin at standard doses was started,which lasted 48 wk,and sustained viral response was achieved.A second liver biopsy showed disappearance of granulomas and chest radiography revealed normalization of mediastinal and perihilar glands.The hypothesis that HCV infection per se may have triggered systemic sarcoidosis was proposed.Successful treatment of HCV infection led to continuous remission of pulmonary and hepatic sarcoidosis.Further studies are required to understand the relationship between systemic sarcoidosis and HCV infection.
基金
Supported by A grant from the Estonian Science Foundation,No.7650
a grant from the University of Tartu,No. SF0180081s07